Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 22041323)

1.

Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.

Horwich TB, Middlekauff HR, Maclellan WR, Fonarow GC.

J Card Fail. 2011 Nov;17(11):879-86. doi: 10.1016/j.cardfail.2011.07.008. Epub 2011 Sep 3.

2.

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV.

J Am Coll Cardiol. 2006 Jan 17;47(2):332-7. Epub 2005 Dec 20.

3.

Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure.

Deo SH, Fisher JP, Vianna LC, Kim A, Chockalingam A, Zimmerman MC, Zucker IH, Fadel PJ.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H377-85. doi: 10.1152/ajpheart.00289.2012. Epub 2012 Jun 1.

4.

Sympathoinhibition by atorvastatin in hypertensive patients.

Gomes ME, Tack CJ, Verheugt FW, Smits P, Lenders JW.

Circ J. 2010 Nov;74(12):2622-6. Epub 2010 Oct 9.

5.

Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction.

Silver MA, Langsjoen PH, Szabo S, Patil H, Zelinger A.

Am J Cardiol. 2004 Nov 15;94(10):1306-10.

PMID:
15541254
6.

Atorvastatin reduces sympathetic activity in patients with chronic kidney disease.

Siddiqi L, Joles JA, Oey PL, Blankestijn PJ.

J Hypertens. 2011 Nov;29(11):2176-80. doi: 10.1097/HJH.0b013e32834ae3c7.

PMID:
21897294
7.

Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.

Stypmann J, Schubert A, Welp H, Schulte H, Assmann G, Breithardt G, Nofer JR.

Clin Cardiol. 2008 Oct;31(10):478-81. doi: 10.1002/clc.20273.

PMID:
18855352
8.

HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.

Bauersachs J, Störk S, Kung M, Waller C, Fidler F, Hoyer C, Frantz S, Weidemann F, Ertl G, Angermann CE.

Eur J Clin Invest. 2007 Nov;37(11):852-9.

PMID:
17973781
9.

The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.

Mozaffarian D, Minami E, Letterer RA, Lawler RL, McDonald GB, Levy WC.

Am J Cardiol. 2005 Dec 15;96(12):1699-704. Epub 2005 Oct 28.

PMID:
16360360
10.

Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.

Abulhul E, McDonald K, Martos R, Phelan D, Spiers JP, Hennessy M, Baugh J, Watson C, O'Loughlin C, Ledwidge M.

Clin Ther. 2012 Jan;34(1):91-100. doi: 10.1016/j.clinthera.2011.11.002. Epub 2011 Dec 9.

PMID:
22154198
11.

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M.

Am Heart J. 2007 Jun;153(6):1055.e1-8.

PMID:
17540209
12.

A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.

Thompson PD, Parker BA, Clarkson PM, Pescatello LS, White CM, Grimaldi AS, Levine BD, Haller RG, Hoffman EP.

Prev Cardiol. 2010 Summer;13(3):104-11. doi: 10.1111/j.1751-7141.2009.00063.x.

13.

Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure.

Usui K, Bradley TD, Spaak J, Ryan CM, Kubo T, Kaneko Y, Floras JS.

J Am Coll Cardiol. 2005 Jun 21;45(12):2008-11.

14.

Atorvastatin and statins in the treatment of heart failure.

Horwich TB, MacLellan WR.

Expert Opin Pharmacother. 2007 Dec;8(17):3061-8. Review.

PMID:
18001265
15.

The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial.

Roveda F, Middlekauff HR, Rondon MU, Reis SF, Souza M, Nastari L, Barretto AC, Krieger EM, Negrão CE.

J Am Coll Cardiol. 2003 Sep 3;42(5):854-60.

16.
17.

Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.

Beckman JA, Liao JK, Hurley S, Garrett LA, Chui D, Mitra D, Creager MA.

Circ Res. 2004 Jul 23;95(2):217-23. Epub 2004 Jun 3.

18.

Sympathoinhibitory effect of statins in chronic heart failure.

Gomes ME, Lenders JW, Bellersen L, Verheugt FW, Smits P, Tack CJ.

Clin Auton Res. 2010 Apr;20(2):73-8. doi: 10.1007/s10286-009-0041-2. Epub 2009 Dec 4.

19.

Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.

Liu G, Zheng XX, Xu YL, Lu J, Hui RT, Huang XH.

Heart Lung Circ. 2014 Oct;23(10):970-7. doi: 10.1016/j.hlc.2014.05.005. Epub 2014 May 28. Review.

PMID:
24954758
20.

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators.

JAMA. 2004 Mar 3;291(9):1071-80.

PMID:
14996776
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk